Skip to main content
SpringerLink
Log in

The relationship between histopathological findings in oral squamous cell carcinoma and FDG uptake on PET

  • Original Article
  • Published:
Oral Radiology Aims and scope Submit manuscript

Abstract

Objectives

It is known that, in fluorine-18 fluorodeoxyglucose Positron Emission Tomography (FDG PET) for the diagnosis of oral cancer, FDG uptake may vary even among different cases of the same squamous cell carcinoma. However, the details of this phenomenon have not yet been elucidated. In this study, we analyzed the relationship between histopathological findings in oral squamous cell cancer and PET findings on FDG uptake.

Methods

We examined 45 patients with oral squamous cell carcinoma who had undergone FDG PET before treatment. FDG uptake was assessed by a standardized uptake value (SUV) calculated according to the PET-measured tissue concentration of FDG, the administered dose of radionuclide, and the body weight of the patient. The relationship between the mean SUV and each of the following parameters was examined: histological grade of malignancy, degree of cell differentiation, size and/or local extent of the primary lesion, and cell density of the tumor.

Results

The mean SUV of FDG uptake did not depend on the histological grade of malignancy or on the degree of cell differentiation, but tended to be greater the larger the primary lesion. SUV also depended on cell density, increasing with the percentage of tumor parenchyma.

Conclusions

It is concluded that cancer cell density greatly influences the SUV of FDG, in that a tumor with fewer cellular elements in cancer tissue tends to become a false negative.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Warburg O. On the origin of cancer cells. Science 1956; 123: 309–14.

    PubMed  Google Scholar 

  2. Gallagher BM, Fowler JS, Gutterson NI, MacGregor RR, Wan CN, Wolf AP: Metabolic trapping as a principle of oradiopharmaceutical design: some factors responsible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. J Nucl Med 1978; 19: 1154–61.

    PubMed  Google Scholar 

  3. Macfarlane DJ, Cotton L, Ackermann RJ, Minn H, Ficaro EP, Shreve PD et al. Triple-head SPECT with 2-[fluorine-18] fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET. Radiology 1995; 194: 425–9.

    PubMed  Google Scholar 

  4. Martin WH, Delbeke D, Patton JA, Sandler MP. Detection of malignancies with SPECT versus PET, with 2-[fluorine-18] fluoro-2-deoxy-D-glucose. Radiology 1996; 198: 225–31.

    PubMed  Google Scholar 

  5. Patz EF Jr, Lowe VJ, Hoffman JM, Paine SS, Harris LK, Goodman PC. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose. Radiology 1994; 191: 379–82.

    PubMed  Google Scholar 

  6. Inoue T, Kim EE, Komaki R, Wong FC, Bassa P, Wong WH et al. Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med 1995;36: 788–93.

    PubMed  Google Scholar 

  7. Strauss LG, Clorius JH, Schlag P, Lehner B, Kimmig B, Engenhart R et al. Recurrence of colorectal tumors: PET evaluation. Radiology 1989; 170: 329–32.

    PubMed  Google Scholar 

  8. Fischbein NJ, Aassar OS, Caputo GR, Kaplan MJ, Singer MI, Price DC et al. Clinical utility positron emission tomography with18F-fluorode-oxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. Am J Neuroradiol 1988; 19: 1189–96.

    Google Scholar 

  9. Di Chiro G, DeLaPaz RL, Brooks RA, Sokoloff L, Kornblith PL, Smith BH, et al. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology 1982; 32: 1323–9.

    PubMed  Google Scholar 

  10. Minn H, Joensuu H, Ahonen A, Klemi P. Fluoro-deoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors. Cancer 1988; 61: 1776–81.

    Article  PubMed  Google Scholar 

  11. Duhaylongsod FG, Lowe VJ, Patz EF Jr, Vaughn AL, Coleman RE, Wolfe WG. Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. Ann Thorac Surg 1995; 60: 1348–52.

    Article  PubMed  Google Scholar 

  12. Minn H, Lapela M, Klemi PJ, Grenman R, Leskinen S, Lindholm P et al. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med 1997; 38: 1907–11.

    PubMed  Google Scholar 

  13. Cook GJ, Maisey MN, Fogelman I. Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine. Eur J Nucl Med 1999; 26: 1363–78.

    Article  PubMed  Google Scholar 

  14. Wahl RL, Henry CA, Ethier SP. Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma. Radiology 1992; 183: 643–7.

    PubMed  Google Scholar 

  15. Jakobsson PA, Eneroth CM, Killander D, Moberger G, Martensson B. Histologic classification and grading of malignancy in carcinoma of the larynx. Acta Radiol Ther Phys Biol 1973; 12: 1–8.

    PubMed  Google Scholar 

  16. Willen R, Nathanson A, Moberger G, Anneroth G. Squamous cell carcinoma of the gingiva. Histological classification and grading of malignancy. Acta Otolaryngol (Stockh) 1975; 79: 146–54.

    Article  Google Scholar 

  17. Pindborg JJ, Smith CJ, van der Waal I. Histological typing of cancer and precancer of the oral mucosa. 2nd ed. Berlin Springer; 1997.

    Google Scholar 

  18. Hermanek P, Sobin LH TNM classification of malignant tumors. 4th ed. Tokyo: Springer-Verlag: 1987.

    Google Scholar 

  19. Shozushima M, Moriguchi H, Shoji S, Sakamaki K, Ishikawa Y, Kudo K et al. Clinical study of the image fusion between CT and FDG-PET in the head and neck region. Dent J Iwate Med Univ 1999; 24: 28–35 (in Japanese)

    Google Scholar 

  20. Vansteenkiste JF, Stroobants SG, Dupont PJ, De Leyn PR, Verbeken EK, Deneffe GJ et al. Prognostic importance of the standardized uptake value on18F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group. J Clin Oncol 1999; 17: 3201–6.

    PubMed  Google Scholar 

  21. Oshida M, Uno K, Suzuki M, Nagashima T, Hashimoto H, Yagata H et al. Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose. Cancer 1998; 82: 2227–34.

    Article  PubMed  Google Scholar 

  22. Halfpenny W, Hain SF, Biassoni L, Maisey MN, Sherman JA, McGurk M. FDG-PET. A possible prognostic factor in head and neck cancer. Br J Cancer 2002; 86: 512–6.

    Article  PubMed  Google Scholar 

  23. Higashi K, Matsunari I, Ueda Y, Ikeda R, Guo J, Oguchi M et al. Value of whole-body FDG PET in management of lung cancer. Ann Nucl Med 2003; 17: 1–14.

    PubMed  Google Scholar 

  24. Reisser C, Haberkorn U, Strauss LG. The relavance of positron emission tomography for the diagnosis and treatment of head and neck tumors. J Otolaryngol 1993; 22: 231–8.

    PubMed  Google Scholar 

  25. Nakasone Y, Inoue T, Oriuchi N, Takeuchi K, Negishi A, Endo K et al. The role of whole-body FDG-PET in preoperative assessment of tumor staging in oral cancers. Ann Nucl Med 2001; 15: 505–12.

    Article  PubMed  Google Scholar 

  26. Brown RS, Leung JY, Kison PV, Zasadny KR, Flint A, Wahl RL. Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer. J Nucl Med 1999; 40: 556–65.

    PubMed  Google Scholar 

  27. Moriguchi H, Shozushima M. Cell cycle dependency of FDG and67Ga citrate uptake in HeLa S3 cells. Dent J Iwate Med Univ 2002; 27: 270–8 (in Japanese).

    Google Scholar 

  28. Higashi K, Clavo AC, Wahl RL. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med 1993; 34: 414–9.

    PubMed  Google Scholar 

  29. Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-flurodeoxyglucose uptake. J Nucl Med 1994; 35: 104–12.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dental Radiology, School of Dentistry, Iwate Medical University, 1-3-27 Chuo-dori, 020-8505, Morioka, Iwate-ken, Japan

    Mitsuru Izumisawa DDS & Masanori Shozushima DDS, PhD

  2. Department of Oral Pathology, School of Dentistry, Iwate Medical University, 1-3-27 Chuo-dori, 020-8505, Morioka, Iwate-ken, Japan

    Hirotaka Sato DDS, PhD

Authors
  1. Mitsuru Izumisawa DDS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masanori Shozushima DDS, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hirotaka Sato DDS, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masanori Shozushima DDS, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Izumisawa, M., Shozushima, M. & Sato, H. The relationship between histopathological findings in oral squamous cell carcinoma and FDG uptake on PET. Oral Radiol. 19, 47–55 (2003). https://doi.org/10.1007/BF02493241

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02493241

Key Words

Search

Navigation